Login / Signup

Impact of the 340B Drug Pricing Program on Cancer Care Site and Spending in Medicare.

Jeah JungWendy Yi XuYamini Kalidindi
Published in: Health services research (2018)
The 340B program shifted the site of cancer drug administration to HOPDs and increased spending on other cancer care. As the program expands, continuing assessment of its impact on service utilization and spending would be needed.
Keyphrases
  • drug administration
  • quality improvement
  • papillary thyroid
  • mental health
  • healthcare
  • squamous cell
  • emergency department
  • young adults
  • medical education
  • adverse drug
  • drug induced
  • affordable care act